• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Wave Life Sciences Ltd. - Ordinary Shares (NQ:WVE)

    7.260 +0.210 (+2.98%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Wave Life Sciences Ltd. - Ordinary Shares

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    These Analysts Revise Their Forecasts On Wave Life Sciences Following Q3 Results
     
    Via Benzinga
    Wave Life Sciences (WVE) Earnings Transcript
    Wave Life Sciences (WVE) Earnings Transcript 
    Via The Motley Fool
    Wave Life Sciences Ltd (NASDAQ:WVE) Reports Q3 2025 Earnings Miss, Stock Falls
    Wave Life Sciences reported mixed Q3 2025 results, missing on revenue and EPS. Despite the financial miss, the biotech highlighted strong clinical progress for its obesity and AATD programs. 
    Via Chartmill
    Topics Earnings
    Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    Earnings Scheduled For November 10, 2025
     
    Via Benzinga
    Peering Into WAVE Life Sciences's Recent Short Interest
     
    Via Benzinga
    Wave Life Sciences Tumbled 19% Today, But Not Everyone’s Disappointed – Find Out Why
    Via Stocktwits
    Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally
    The biotech sector is currently experiencing a robust rally, a significant turnaround from a period of subdued performance. This resurgence is primarily fueled by a wave of promising drug trial results... 
    Via MarketMinute
    Topics Artificial Intelligence Intellectual Property
    A Look Ahead: WAVE Life Sciences's Earnings Forecast
     
    Via Benzinga
    Wave Life Sciences to Present at Upcoming Investor Conferences
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    Wave Life Sciences to Present Preclinical Data Supporting Therapeutic Potential of WVE-007 for Obesity at ObesityWeek® 2025
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    Wave Life Sciences Third Quarter 2025 Financial Results Scheduled for November 10, 2025
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    Keep an eye on the top gainers and losers in Wednesday's session.
    Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
    Via Chartmill
    12 Health Care Stocks Moving In Wednesday's Intraday Session
     
    Via Benzinga
    Deep Dive Into WAVE Life Sciences Stock: Analyst Perspectives (6 Ratings)
     
    Via Benzinga
    Wave Life Sciences Announces Virtual Research Day on October 29th and Participation at Upcoming Investor Conferences
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    Top movers analysis one hour before the close of the markets on 2025-09-03: top gainers and losers in today's session.
    Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
    Via Chartmill
    Forecasting The Future: 7 Analyst Projections For WAVE Life Sciences
     
    Via Benzinga
    Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday?
    Wave Life Sciences shares early WVE-006 trial results in alpha-1 antitrypsin deficiency, reporting durable protein production and favorable safety. 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
     
    Via Benzinga
    Crude Oil Falls Over 2%; Campbell's Earnings Top Estimates
     
    Via Benzinga
    Wednesday's session: gap up and gap down stocks
    Today's session on Wednesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
    Via Chartmill
    Nasdaq Gains Over 100 Points; Dollar Tree Post Upbeat Earnings
     
    Via Benzinga
    Which stocks are moving before the opening bell on Wednesday?
    Wondering what's happening in Wednesday's pre-market session? Find an overview in this article. 
    Via Chartmill
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
     
    Via Benzinga
    Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
     
    Via Benzinga
    Beyond The Numbers: 6 Analysts Discuss WAVE Life Sciences Stock
     
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.